3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neutropenia
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Hemorrhage
1
Febrile Neutropenia
1
Anastomotic Leak
1
Interventions
trifluridine tipiracil drug combination
1
Vancomycin
1
Teicoplanin
1
Ofloxacin
1
Metronidazole
1
Meropenem
1
Levofloxacin
1
Ciprofloxacin
1
Ceftazidime
1
Cefepime
1
Bevacizumab
1
Amikacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Neutropenia
×
Levofloxacin
×
Clear all
NCT07528417
2026-04-22
MYELO-CAN:ABX
University of Manitoba
Phase 2
Not yet recruiting
75 enrolled